210 related articles for article (PubMed ID: 27435900)
1. Crystal structure of mammalian acid sphingomyelinase.
Gorelik A; Illes K; Heinz LX; Superti-Furga G; Nagar B
Nat Commun; 2016 Jul; 7():12196. PubMed ID: 27435900
[TBL] [Abstract][Full Text] [Related]
2. The structure and catalytic mechanism of human sphingomyelin phosphodiesterase like 3a--an acid sphingomyelinase homologue with a novel nucleotide hydrolase activity.
Lim SM; Yeung K; Trésaugues L; Ling TH; Nordlund P
FEBS J; 2016 Mar; 283(6):1107-23. PubMed ID: 26783088
[TBL] [Abstract][Full Text] [Related]
3. Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.
Zhou YF; Metcalf MC; Garman SC; Edmunds T; Qiu H; Wei RR
Nat Commun; 2016 Oct; 7():13082. PubMed ID: 27725636
[TBL] [Abstract][Full Text] [Related]
4. Structural Basis for Nucleotide Hydrolysis by the Acid Sphingomyelinase-like Phosphodiesterase SMPDL3A.
Gorelik A; Illes K; Superti-Furga G; Nagar B
J Biol Chem; 2016 Mar; 291(12):6376-85. PubMed ID: 26792860
[TBL] [Abstract][Full Text] [Related]
5. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
[TBL] [Abstract][Full Text] [Related]
6. Structure of Human Acid Sphingomyelinase Reveals the Role of the Saposin Domain in Activating Substrate Hydrolysis.
Xiong ZJ; Huang J; Poda G; Pomès R; Privé GG
J Mol Biol; 2016 Jul; 428(15):3026-42. PubMed ID: 27349982
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional analysis of the ASM p.Ala359Asp mutant that causes acid sphingomyelinase deficiency.
Acuña M; Castro-Fernández V; Latorre M; Castro J; Schuchman EH; Guixé V; González M; Zanlungo S
Biochem Biophys Res Commun; 2016 Oct; 479(3):496-501. PubMed ID: 27659707
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of SMPD1 mutations in Asian-Indian patients with acid sphingomyelinase (ASM)-deficient Niemann-Pick disease.
Ranganath P; Matta D; Bhavani GS; Wangnekar S; Jain JM; Verma IC; Kabra M; Puri RD; Danda S; Gupta N; Girisha KM; Sankar VH; Patil SJ; Ramadevi AR; Bhat M; Gowrishankar K; Mandal K; Aggarwal S; Tamhankar PM; Tilak P; Phadke SR; Dalal A
Am J Med Genet A; 2016 Oct; 170(10):2719-30. PubMed ID: 27338287
[TBL] [Abstract][Full Text] [Related]
9. Identification and biochemical characterization of an acid sphingomyelinase-like protein from the bacterial plant pathogen Ralstonia solanacearum that hydrolyzes ATP to AMP but not sphingomyelin to ceramide.
Airola MV; Tumolo JM; Snider J; Hannun YA
PLoS One; 2014; 9(8):e105830. PubMed ID: 25144372
[TBL] [Abstract][Full Text] [Related]
10. Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models.
Jones I; He X; Katouzian F; Darroch PI; Schuchman EH
Mol Genet Metab; 2008 Nov; 95(3):152-62. PubMed ID: 18815062
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease.
Moles A; Tarrats N; Fernández-Checa JC; Marí M
J Biol Chem; 2012 Jan; 287(2):1178-88. PubMed ID: 22102288
[TBL] [Abstract][Full Text] [Related]
12. Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis.
Deigner HP; Claus R; Bonaterra GA; Gehrke C; Bibak N; Blaess M; Cantz M; Metz J; Kinscherf R
FASEB J; 2001 Mar; 15(3):807-14. PubMed ID: 11259399
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing.
Jenkins RW; Idkowiak-Baldys J; Simbari F; Canals D; Roddy P; Riner CD; Clarke CJ; Hannun YA
J Biol Chem; 2011 Feb; 286(5):3777-88. PubMed ID: 21098024
[TBL] [Abstract][Full Text] [Related]
14. Acid sphingomyelinase (aSMase) deficiency leads to abnormal microglia behavior and disturbed retinal function.
Dannhausen K; Karlstetter M; Caramoy A; Volz C; Jägle H; Liebisch G; Utermöhlen O; Langmann T
Biochem Biophys Res Commun; 2015 Aug; 464(2):434-40. PubMed ID: 26129774
[TBL] [Abstract][Full Text] [Related]
15. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
Schuchman EH
FEBS Lett; 2010 May; 584(9):1895-900. PubMed ID: 19944693
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the sphingomyelin phosphodiesterase 1 gene (SMPD1) in Turkish Niemann-Pick disease patients: mutation profile and description of a novel mutation.
Aykut A; Karaca E; Onay H; Ucar SK; Coker M; Cogulu O; Ozkinay F
Gene; 2013 Sep; 526(2):484-6. PubMed ID: 23618813
[TBL] [Abstract][Full Text] [Related]
17. A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase.
Seto M; Whitlow M; McCarrick MA; Srinivasan S; Zhu Y; Pagila R; Mintzer R; Light D; Johns A; Meurer-Ogden JA
Protein Sci; 2004 Dec; 13(12):3172-86. PubMed ID: 15557261
[TBL] [Abstract][Full Text] [Related]
18. Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease.
Lin N; Zhang H; Qiu W; Ye J; Han L; Wang Y; Gu X
J Lipid Res; 2014 Feb; 55(2):338-43. PubMed ID: 24190732
[TBL] [Abstract][Full Text] [Related]
19. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease).
Otterbach B; Stoffel W
Cell; 1995 Jun; 81(7):1053-61. PubMed ID: 7600574
[TBL] [Abstract][Full Text] [Related]
20. A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate.
van Diggelen OP; Voznyi YV; Keulemans JL; Schoonderwoerd K; Ledvinova J; Mengel E; Zschiesche M; Santer R; Harzer K
J Inherit Metab Dis; 2005; 28(5):733-41. PubMed ID: 16151905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
